Receptor tyrosine kinase KIT: Prognostic and therapeutic involvement in canine mast cell tumours

被引：2
|
作者：
Takeuchi, Yoshinori [1 ]
Bonkobara, Makoto [2 ]
机构：
[1] Pharmaceut & Med Devices Agcy, Off Med Informat & Epidemiol, Chiyoda Ku, 3-3-2 Kasumigaseki, Tokyo 1000013, Japan
[2] Nippon Vet & Life Sci Univ, Dept Vet Clin Pathol, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan
来源：
VETERINARY JOURNAL | 2016年 / 210卷
关键词：
C-KIT; INHIBITORS;
D O I：
10.1016/j.tvjl.2015.07.012
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [31] Canine oral mucosal mast cell tumours
    Elliott, J. W.
    Cripps, P.
    Blackwood, L.
    Berlato, D.
    Murphy, S.
    Grant, I. A.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2016, 14 (01) : 101 - 111
  • [32] Expression of receptor tyrosine kinase targets PDGFR-, VEGFR2 and KIT in canine transitional cell carcinoma
    Walters, L.
    Martin, O.
    Price, J.
    Sula, M. M.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : E117 - E122
  • [33] Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
    Koo, Karen
    Wuenschmann, Arno
    Rendahl, Aaron
    Song, Kyu Young
    Forster, Colleen
    Wolf-Ringwall, Amber
    Borgatti, Antonella
    Giubellino, Alessio
    VETERINARY SCIENCES, 2023, 10 (04)
  • [34] The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
    Drube, Sebastian
    Heink, Sylvia
    Walter, Sabine
    Loehn, Tobias
    Grusser, Mandy
    Gerbaulet, Alexander
    Berod, Luciana
    Schons, Julia
    Dudeck, Anne
    Freitag, Jenny
    Grotha, Stefan
    Reich, Daniela
    Rudeschko, Olga
    Norgauer, Johannes
    Hartmann, Karin
    Roers, Axel
    Kamradt, Thomas
    BLOOD, 2010, 115 (19) : 3899 - 3906
  • [35] Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines
    Takeuchi, Yoshinori
    Fujino, Yasuhito
    Watanabe, Manabu
    Nakagawa, Takayuki
    Ohno, Koichi
    Sasaki, Nobuo
    Sugano, Sumio
    Tsujimoto, Hajime
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2010, 137 (3-4) : 208 - 216
  • [36] Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours
    Marconato, Laura
    Polton, Gerry
    Stefanello, Damiano
    Morello, Emanuela
    Ferrari, Roberta
    Henriques, Joaquim
    Tortorella, Giovanni
    Benali, Silvia L.
    Bergottini, Raffaella
    Vasconi, Maria E.
    Annoni, Maurizio
    Sabattini, Silvia
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (04) : 580 - 589
  • [37] Mutation and methylation status of KIT and TP53 in canine cutaneous and subcutaneous mast cell tumours
    Vozdova, Miluse
    Kubickova, Svatava
    Fictum, Petr
    Cernohorska, Halina
    Froehlich, Jan
    Rubes, Jiri
    VETERINARY AND COMPARATIVE ONCOLOGY, 2020, 18 (03) : 438 - 444
  • [38] The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors
    Kiupel, M
    Webster, JD
    Kaneene, JB
    Miller, R
    Yuzbasiyan-Gurkan, V
    VETERINARY PATHOLOGY, 2004, 41 (04) : 371 - 377
  • [39] KIT RECEPTOR EXPRESSION IN CANINE CUTANEOUS MAST CELL TUMORS (CMCTs) WITHOUT C-KIT MUTATION
    Vucicevic, Ivana
    Marinkovic, Darko
    Kukolj, Vladimir
    Vucicevic, Milos
    Mirilovic, Milorad
    Nesic, Sladan
    Aleksic-Kovacevic, Sanja
    ACTA VETERINARIA-BEOGRAD, 2016, 66 (02): : 222 - 233
  • [40] The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours
    Costa Casagrande, T. A.
    de Oliveira Barros, L. M.
    Fukumasu, H.
    Cogliati, B.
    Chaible, L. M.
    Dagli, M. L. Z.
    Matera, J. M.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2015, 13 (01) : 1 - 10
12345